MRNA
$57.46
Revenue | $241Mn |
Net Profits | $-1279Mn |
Net Profit Margins | -530.71% |
Moderna, Inc.’s revenue fell -29.94% since last year same period to $241Mn in the Q2 2024. On a quarterly growth basis, Moderna, Inc. has generated 44.31% jump in its revenue since last 3-months.
Moderna, Inc.’s net profit jumped 7.32% since last year same period to $-1279Mn in the Q2 2024. On a quarterly growth basis, Moderna, Inc. has generated -8.85% fall in its net profits since last 3-months.
Moderna, Inc.’s net profit margin fell -32.29% since last year same period to -530.71% in the Q2 2024. On a quarterly growth basis, Moderna, Inc. has generated 24.57% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.89 |
EPS Estimate Current Year | -1.89 |
Moderna, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.89 - a 44.08% jump from last quarter’s estimates.
Moderna, Inc.’s earning per share (EPS) estimates for the current year stand at -1.89.
Earning Per Share (EPS) | -3.33 |
Moderna, Inc.’s earning per share (EPS) jumped 8.01% since last year same period to -3.33 in the Q2 2024. This indicates that the Moderna, Inc. has generated 8.01% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-01 | -3.38 | -3.33 | 1.48% |
2024-05-02 | -3.58 | -3.07 | 14.25% |